Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | A769662 |
Synonyms | |
Therapy Description |
A769662 is a direct activator of AMP-activated protein kinase (AMPK), potentially resulting antitumor activity in combination with other agents (PMID: 34124601). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
A769662 | A-769662|A 769662 | A769662 is a direct activator of AMP-activated protein kinase (AMPK), potentially resulting antitumor activity in combination with other agents (PMID: 34124601). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|